companies: 6,640     total market cap: $99.7 T
Diffusion Pharmaceuticals Inc.
DFFN

$8.98 M
Marketcap
$4.40
Share price
US
Country
$0.41
Change (1 day)
$14.37
Year High
$4.14
Year Low
Biotechnology
Categories

Diffusion Pharmaceuticals Inc., a biopharmaceutical company, develops novel therapies that enhance the body's ability to deliver oxygen. Its lead product candidate is Trans Sodium Crocetinate that is developed to enhance the diffusion of oxygen to tissues, as well as to treat COVID-19 disease. Diffusion Pharmaceuticals Inc. was founded in 2001 and is based in Charlottesville, Virginia.

marketcap

Stock price history for Diffusion Pharmaceuticals Inc. (DFFN)

Highest end of day price: $9393.75 USD on 2017-01-10

Lowest end of day price: $4.20 USD on 2023-07-06

Stock price history of Diffusion Pharmaceuticals Inc. from 2016 to 2023


What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company. In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

Stock prices are delayed, the delay can range from a few minutes to several hours. MarketCap.tools is not a Financial institution.

Contact

For inquiries or if you want to report a problem write to web@marketcap.tools

© 2023 Marketcap.tools